Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
Indian J Public Health
;
2006 Jan-Mar; 50(1): 43-4
Artículo
en Inglés
| IMSEAR
| ID: sea-109820
ABSTRACT
Along with hepatitis B virus (HBV) and human immunodeficiency virus (HIV), Hepatitis C virus (HCV) is emerging as a major transfusion hazard. 22 cases of haemophilia (A 19, B 3) and 20 cases of thalassaemia (2 16, E(2) 4) constituted the study group. Patients tested for anti HCV (using third generation ELISA), HBsAg and antibodies to HIV I and II. Prevalence of anti HCV was 54.5% in haemophilics and 5% in thalassaemics. HBsAg was detected in 9.09% haemophilics and 5% thalassaemics. No anti HIV was detected in this cohort. Anti HCV seropositivity in haemophilics has increased compare to previous studies.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Talasemia
/
Transfusión Sanguínea
/
Humanos
/
Estudios Seroepidemiológicos
/
Niño
/
Preescolar
/
Prevalencia
/
Adolescente
/
VIH
/
Hepatitis C
Tipo de estudio:
Estudio de etiología
/
Estudio de prevalencia
/
Factores de riesgo
Idioma:
Inglés
Revista:
Indian J Public Health
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS